← FDA DRUG APPROVALS

FDA NDA · NDA011073

WAMPOCAP

Sponsor: MEDPOINTE PHARM HLC

APPLICATION
NDA011073
TYPE
NDA
ORIGINAL APPROVAL
1957-07-24
LATEST ACTION
1957-07-24
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

WAMPOCAPDiscontinued
NIACIN 500MG · CAPSULE · ORAL

Approval history

1957-07-24Type 4 - New Combination · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →